|
⚲
|
| Keyboard |
| Northpond Ventures III GP LLC
✚
|
|
|---|---|
| CIK # | 0002010695 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002010695] | |
| 4 | [0002010695] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Camp4 Therapeutics Corp CAMP
Series B Preferred Stock · derivative
|
2024-10-15 | Conversion | 5,287,303 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 471,415 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Buy | 763,636 | $11.00 | 8,399,996 |
|
Camp4 Therapeutics Corp CAMP
Series A Prime Preferred Stock · derivative
|
2024-10-15 | Conversion | 11,251,624 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 1,003,193 | ||
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 2,805,426 | ||
|
Kyverna Therapeutics Inc KYTX
Series B Preferred Stock · derivative
|
2024-02-12 | Conversion | 12,767,776 | ||
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Buy | 450,000 | $22.00 | 9,900,000 |